Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Neurofibromatosis 1 × Curcumin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Uterine Cervical Dysplasia 1 Stomatitis 1 Rectal Neoplasms 1 Pain 1 Neurofibromatosis 1 1 Lung Neoplasms 1 Castration Sensitive Prostate Cancer 1 Breast Neoplasms 1 Advanced Cancers 1

Interventions

Deoxycholic Acid 4 AZD 6244 3 Polidocanol 2 Lasers, Solid-State 2 talimogene laherparepvec 1 pomalidomide 1 pirfenidone 1 lorlatinib 1 encorafenib 1 diphenylcyclopropenone 1 cabozantinib 1 binimetinib 1 X-Rays 1 Vinblastine 1 Specimen Handling 1 Sorafenib 1 Photons 1 Pharmacokinetics 1 Magnetic Resonance Spectroscopy 1 Lovastatin 1 Lasers 1 Imiquimod 1 High-Energy Shock Waves 1 Curcumin 1 Cetuximab 1 Carboplatin 1 Biopsy 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05363267 2026-01-13

NF-1, Nutraceutical Intervention

Masonic Cancer Center, University of Minnesota

Phase 1 Active not recruiting

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡